Institution statistics

H. LUNDBECK AS - Denmark 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 17
As coordinator: 0
As participant: 17
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 21.982.717 297.522 4
2018 0 8.599.301 0 2
2017 0 13.785.600 48.750 3
2016 0 37.541.828 365.082 6
2012 0 11.978.735 39.999 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV8
ELI LILLY AND COMPANY LIMITED5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE4
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV4
F HOFFMANNLA ROCHE4
NOVARTIS PHARMA4
NOVO NORDISK4
UCB BIOPHARMA4
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
KING'S COLLEGE LONDON3
PFIZER LIMITED3
REGION HOVEDSTADEN3
STICHTING VUMC3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
UNIVERSITY OF AARHUS3
UNIVERSITY OF COPENHAGEN3
ALZHEIMER EUROPE2
ARTTIC2
BIOGEN IDEC LIMITED2
CONSIGLIO NAZIONALE DELLE RICERCHE2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUJIFILM CELLULAR DYNAMICS INC2
GOETEBORGS UNIVERSITET2
INSTITUT DE RECHERCHES SERVIER2
KATHOLIEKE UNIVERSITEIT LEUVEN2
LIFE AND BRAIN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MIMETAS BV2
ORION OYJ2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SKANE LANS LANDSTING2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING VU2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TAKEDA DEVELOPMENT CENTRE EUROPE2
THE UNIVERSITY OF EDINBURGH2
UNIVERSITAETSKLINIKUM BONN2
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF WALES CARDIFF2
UPPSALA UNIVERSITET2
ABBVIE1
ABBVIE DEUTSCHLAND GMBH & CO KG1
AC IMMUNE1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
AMGEN LIMITED1
ARTEMIS BIOSUPPORT BV1
ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON1
ASTON UNIVERSITY1
ASTRAZENECA AB1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AXXAM1
BAYER1
BAYER AKTIENGESELLSCHAFT1
BIOARCTIC AB1
BIONEER1
CARDIFF UNIVERSITY1
CARL ZEISS1
CEGAT1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO1
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE1
CHU HOPITAUX DE BORDEAUX1
COLLEGE DE FRANCE1
CONCENTRIS RESEARCH MANAGEMENT1
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP1
COVANCE LABORATORIES1
DEPARTMENT OF HEALTH1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECKERT & ZIEGLER EUROTOPE1
EISAI LIMITED1
ELYSIA1
ENKAM PHARMACEUTICALS1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN PATIENTS' FORUM1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
EUROTRIALS SCIENTIFIC CONSULTANTS1
EXPLORA NOVA SARL1
FACHHOCHSCHULE NORDWESTSCHWEIZ1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA1
FORENAP PHARMA1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
FUNDACIO SANT JOAN DE DEU1
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O1
GE HEALTHCARE LIMITED1
GENEXPLAIN1
GENOWAY1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
Constancy:

Total number of partners:271

Partner loyalty:
Frequent Partner: (> 2 projects): 66
Rare Partner: 205

Frequent / Rare Partner Ratio: 0.32

Diversity:

Subjects:
Subject:No:
LIFE SCIENCES2
Diversity index:1
Categories:
Category:No:
BIOLOGICAL SCIENCES2

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01Synaptic Dysfunction in Neuropsychiatric Disorders Syn2Psyparticipant3.885.13411
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-02-01PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease PD-MitoQUANTparticipant4.497.93514
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-09-01PET Imaging of Alpha-Synuclein Fibril Formation PET-AlphaSyparticipant4.100.37016
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-03-01Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 IMPRiNDparticipant4.684.99819
2017-01-01Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery TreatERparticipant5.971.17411
2017-01-01Synaptic dysfunction in Neurodegenerative Diseases SYNDEGENparticipant3.129.42814
2016-12-01Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia EU-GliaPhDparticipant3.924.32512
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-05-01Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines PEARRLparticipant3.856.25310
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-01-01Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders COSYNparticipant5.925.00014
2012-01-01Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes TACTICSparticipant6.000.00012
2012-01-01Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders NEUROFGLparticipant5.978.7357
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum